AssayIndex
GGPeps cross-section

GGPeps by compound

GGPeps records split by compound, with the index-wide comparison for the same compound beside each one. 28 compounds, 371 records. Cells below n=3 print their raw values instead of a median.

28 compounds371 records
CompoundClassReportsGGPeps median %Index median %Δ (pp)SpecPass %
RetatrutideIncretin5698.4498.37+0.0796.5100
BPC-157Tissue-repair5698.8299.16-0.3498.0100
TirzepatideIncretin3698.4698.55-0.0997.0100
SemaxNeuroactive2399.3899.46-0.0898.5100
SemaglutideIncretin2398.4698.89-0.4397.0100
LiraglutideIncretin1998.7799.00-0.2397.5100
Enclomiphene citrateNon-peptide1698.3299.44-1.1298.531
CJC-1295 (no DAC)Growth-hormone1598.2799.09-0.8298.087
SurvodutideIncretin1497.6698.38-0.7296.5100
TB-500Tissue-repair1499.5899.53+0.0598.5100
NAD+Non-peptide1298.1699.28-1.1197.0100
IpamorelinGrowth-hormone1099.2099.47-0.2799.080
GHRP-2Growth-hormone1099.1599.28-0.1499.080
SelankNeuroactive999.6299.59+0.0399.078
MK-677 (Ibutamoren mesylate)Non-peptide999.8199.49+0.3298.5100
Melanotan IIMelanocortin-receptor899.2299.42-0.2098.5100
SermorelinGrowth-hormone898.5399.06-0.5298.0100
IGF-1 LR3Growth-hormone5 n=598.1198.28-0.1795.0100
HexarelinGrowth-hormone5 n=599.2899.59-0.3199.080
SLU-PP-332Non-peptide4 n=498.9398.88+0.0698.0100
MGFGrowth-hormone4 n=498.4899.29-0.8197.5100
CagrilintideIncretin3 n=398.1398.69-0.5696.5100
N-Acetyl Semax AmideNeuroactive3 n=398.5799.35-0.7898.567
5-Amino-1MQNon-peptide2 n=2n<399.4598.0100
KPVTissue-repair2 n=2n<399.6499.00
ARA-290Tissue-repair2 n=2n<399.4298.0100
DesmopressinHypothalamic2 n=2n<398.8398.5100
L-Glutathione (reduced)Short1 n=1n<399.3398.5100
97.197.698.198.699.199.6100.1RetatrutideRetatrutide: Q1 98.01, median 98.44, Q3 98.81, n=56n=56BPC-157BPC-157: Q1 98.66, median 98.82, Q3 99.03, n=56outlier 98.05outlier 99.93n=56TirzepatideTirzepatide: Q1 98.19, median 98.46, Q3 99.32, n=36n=36SemaxSemax: Q1 99.18, median 99.38, Q3 99.60, n=23n=23SemaglutideSemaglutide: Q1 98.26, median 98.46, Q3 99.00, n=23n=23LiraglutideLiraglutide: Q1 98.69, median 98.77, Q3 98.96, n=19outlier 99.78n=19Enclomiphene citrateEnclomiphene citrate: Q1 98.12, median 98.32, Q3 98.87, n=16n=16CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 98.07, median 98.27, Q3 98.48, n=15outlier 99.12n=15SurvodutideSurvodutide: Q1 97.61, median 97.66, Q3 97.70, n=14outlier 97.37outlier 97.37outlier 97.44outlier 98.41outlier 98.68n=14TB-500TB-500: Q1 99.33, median 99.58, Q3 99.75, n=14n=14NAD+NAD+: Q1 98.03, median 98.16, Q3 98.35, n=12outlier 97.55n=12IpamorelinIpamorelin: Q1 99.04, median 99.20, Q3 99.34, n=10outlier 99.80n=10GHRP-2GHRP-2: Q1 99.11, median 99.15, Q3 99.18, n=10outlier 98.75outlier 98.80n=10SelankSelank: Q1 99.37, median 99.62, Q3 99.69, n=9outlier 98.87n=9 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines GGPeps actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Nantong Guangyuan Chemical Co., Ltd. lists considerably more than the 28 compounds above. Of those 28, 19 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the GGPeps catalogue at ggpeps.net →